Top worldwide anti-rheumatics by market share 2017 and 2024

Published by
Matej Mikulic,
Nov 9, 2024
This statistic shows the top anti-rheumatic products worldwide by market share in 2017 and a projection for 2024. Enbrel had a market share of 14.8 percent in 2017 which is expected to decrease to 7.2 percent in 2024. Anti-rheumatic drugs are used to treat and slow the progress of rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disease that principally attacks the joints but also impacts tissues and organs.

Top anti-rheumatic products based on global market share in 2017 and 2024

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2018

Region

Worldwide

Survey time period

as of May 2018

Supplementary notes

Anti-tumor necrosis factor alpha (TNFa) inhibitor sales include RA, Crohn's and Psoriasis.
* Projected.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in SingaporePharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical market in the PhilippinesPharmaceutical market in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.